Sökning: id:"swepub:oai:DiVA.org:uu-221985" >
Higher World Health...
Higher World Health Organization grades of follicular lymphoma correlate with better outcome in two Nordic Lymphoma Group trials of rituximab without chemotherapy
-
- Wahlin, Bjorn Engelbrekt (författare)
- Karolinska Institutet
-
- Sundström, Christer (författare)
- Uppsala universitet,Molekylär och morfologisk patologi
-
- Sander, Birgitta (författare)
- Karolinska Institutet
-
visa fler...
-
- Christensson, Birger (författare)
- Karolinska Institutet
-
Jeppsson-Ahlberg, Asa (författare)
-
- Hjalmarsson, Eric (författare)
- Karolinska Institutet
-
Holte, Harald (författare)
-
Ostenstad, Bjorn (författare)
-
Brown, Peter D. (författare)
-
Smeland, Erlend Bremertun (författare)
-
- Kimby, Eva (författare)
- Karolinska Institutet
-
visa färre...
-
(creator_code:org_t)
- 2013-06-14
- 2014
- Engelska.
-
Ingår i: Leukemia and Lymphoma. - : Informa UK Limited. - 1042-8194 .- 1029-2403. ; 55:2, s. 288-295
- Relaterad länk:
-
https://urn.kb.se/re...
-
visa fler...
-
https://doi.org/10.3...
-
http://kipublication...
-
visa färre...
Abstract
Ämnesord
Stäng
- A common treatment for follicular lymphoma is rituximab monotherapy. To identify patients for whom this regimen is adequate as first-line therapy, we applied the World Health Organization (WHO) classification for grading follicular lymphoma in a prospective central pathology review of the biopsies of previously untreated patients in two randomized trials of rituximab without chemotherapy. In the first trial (n(1) = 53), higher WHO grades correlated with longer time to next treatment, independently of clinical prognostic factors (p = 0.030); the finding was replicated in the second trial (n(2) = 221; p = 0.019). Higher grades were associated with better treatment responses (p = 0.018). Furthermore, also grades externally confirmed by independent local pathologists correlated with time to next treatment (p = 0.048). Flow cytometry in a separate patient series showed that the intensity of CD20 increased with the malignant cell size (p < 0.00005). In conclusion, WHO grade 1 follicular lymphoma correlates with inferior outcome after rituximab monotherapy. WHO grading might provide a clinically useful tool for personalized therapy.
Nyckelord
- Follicular lymphoma
- WHO
- grades
- rituximab
- CD20
Publikations- och innehållstyp
- ref (ämneskategori)
- art (ämneskategori)
Hitta via bibliotek
Till lärosätets databas
- Av författaren/redakt...
-
Wahlin, Bjorn En ...
-
Sundström, Chris ...
-
Sander, Birgitta
-
Christensson, Bi ...
-
Jeppsson-Ahlberg ...
-
Hjalmarsson, Eri ...
-
visa fler...
-
Holte, Harald
-
Ostenstad, Bjorn
-
Brown, Peter D.
-
Smeland, Erlend ...
-
Kimby, Eva
-
visa färre...
- Artiklar i publikationen
-
Leukemia and Lym ...
- Av lärosätet
-
Uppsala universitet
-
Karolinska Institutet